These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37507150)

  • 1. Cardiac magnetic relaxometry versus ejection fraction in anthracycline-related cardiac changes: a systematic review and meta-analysis.
    Yu C; Pathan S; Jeyaprakash P; Kritharides L; Pathan F; Negishi K
    Open Heart; 2023 Jul; 10(2):. PubMed ID: 37507150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis.
    Musella F; Librera M; Sibilio G; Boccalatte M; Tagliamonte G; Cavaglià E; Ferrara I; Puglia M; Dell'Aversana S; Ducci CB; Dellegrottaglie S; Savarese G; Scatteia A
    Curr Probl Cardiol; 2024 Jul; 49(7):102609. PubMed ID: 38697332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
    Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
    Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
    J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer.
    Thavendiranathan P; Shalmon T; Fan CS; Houbois C; Amir E; Thevakumaran Y; Somerset E; Malowany JM; Urzua-Fresno C; Yip P; McIntosh C; Sussman MS; Brezden-Masley C; Yan AT; Koch CA; Spiller N; Abdel-Qadir H; Power C; Hanneman K; Wintersperger BJ
    JAMA Cardiol; 2023 Jun; 8(6):524-534. PubMed ID: 37043251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
    Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
    Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
    Muehlberg F; Kornfeld M; Zange L; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
    ESC Heart Fail; 2023 Feb; 10(1):616-627. PubMed ID: 36404640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
    Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
    Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101033. PubMed ID: 38460840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
    Neilan TG; Coelho-Filho OR; Shah RV; Feng JH; Pena-Herrera D; Mandry D; Pierre-Mongeon F; Heydari B; Francis SA; Moslehi J; Kwong RY; Jerosch-Herold M
    Am J Cardiol; 2013 Mar; 111(5):717-22. PubMed ID: 23228924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.
    Muehlberg F; Funk S; Zange L; von Knobelsdorff-Brenkenhoff F; Blaszczyk E; Schulz A; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
    ESC Heart Fail; 2018 Aug; 5(4):620-629. PubMed ID: 29673122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective multiparametric CMR characterization and MicroRNA profiling of anthracycline cardiotoxicity: A pilot translational study.
    Harries I; Biglino G; Ford K; Nelson M; Rego G; Srivastava P; Williams M; Berlot B; De Garate E; Baritussio A; Liang K; Baquedano M; Chavda N; Lawton C; Shearn A; Otton S; Lowry L; Nightingale AK; Carlos Plana J; Marks D; Emmanueli C; Bucciarelli-Ducci C
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101134. PubMed ID: 36389268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
    Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of anthracycline-induced myocardial injury using serial cardiac magnetic resonance: An animal study.
    Wang R; Zhou Z; Schoepf UJ; Varga-Szemes A; Strigenz A; Wang H; Liu Y; Xu L
    Int J Cardiol; 2021 Apr; 328():111-116. PubMed ID: 33359332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors.
    Mawad W; Mertens L; Pagano JJ; Riesenkampff E; Reichert MJE; Mital S; Kantor PF; Greenberg M; Liu P; Nathan PC; Grosse-Wortmann L
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):435-442. PubMed ID: 32535624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.
    Yuan Y; Cai J; Cui Y; Wang J; Alwalid O; Shen X; Cao Y; Zou Y; Liang B
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1959-1967. PubMed ID: 30056496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.
    Mavrogeni SI; Sfikakis PP; Markousis-Mavrogenis G; Bournia VK; Poulos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Boki K; Vartela V; Kolovou G; Theodorakis G; Kitas GD
    Int J Cardiol; 2019 Jun; 284():105-109. PubMed ID: 30404725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.